Pregabalin and Speech Pathology Treatment for Refractory Chronic Cough with Laryngeal Hypersensitivity

普瑞巴林和言语病理学治疗伴有喉部过敏的难治性慢性咳嗽

• 批准号: nhmrc : 1072056
• 金额: $ 10.39万
• 依托单位: The University of Newcastle
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2014
• 资助国家: 澳大利亚
• 起止时间: 2014-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/pregabalin-speech-pathology-laryngeal-hypersensitivity/455488
• 关键词: Pregabalin; Speech; Pathology; Treatment; Refractory

Persistent cough that does not respond to medical treatment is debilitating and frustrating for the sufferer and very expensive for the Australian government. This research will provide a new and effective treatment option and extend our current reputation as the world leader in the identification and treatment of refractory chronic cough. This treatment strategy has not been trialled before and the findings will change current medical practice and significantly reduce community health costs.

持续咳嗽，不响应医疗是衰弱和令人沮丧的患者和非常昂贵的澳大利亚政府。这项研究将提供一个新的和有效的治疗选择，并扩大我们目前的声誉，作为世界领先的识别和治疗难治性慢性咳嗽。这种治疗策略以前没有试验过，研究结果将改变目前的医疗实践，并大大降低社区卫生费用。